NMM
DNLI icon

Naples Money Management’s Denali Therapeutics DNLI Stock Holding History

Naples Money Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-45
Closed -$923 – 404
2024
Q1 		$923 Buy
45
+12
+36% +$226 ﹤0.01% 363
2023
Q4 		$708 Buy
+33
New +$654 ﹤0.01% 383

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Naples Money Management's DNLI Position: Q2 2024 in Review

Naples Money Management sold out of Denali Therapeutics (DNLI) in Q2 2024, closing a stake of 45 shares — an estimated $923 sold.

Naples Money Management first reported a position in DNLI in Q4 2023 and held it in 2 quarters. The position peaked at $923 in Q1 2024. 203 funds tracked by Wall St. Rank hold DNLI as of Q2 2024.

  • Naples Money Management reported no remaining Denali Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Naples Money Management sold 45 Denali Therapeutics shares in Q2 2024, an estimated $923.
  • Naples Money Management first reported a position in Denali Therapeutics in Q4 2023 and held it in 2 quarters.
  • Naples Money Management's Denali Therapeutics position peaked at $923 in Q1 2024.
  • 203 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2024.

Based on Naples Money Management's 13F filing for Q2 2024, filed 9 Jul 2024.